A giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report (Second Report) ...

A bipartisan, bicameral group of lawmakers is calling on the Federal Trade Commission (FTC) to vote in favor of releasing an interim staff report on pharmacy benefit managers (PBM). Sens.

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...

Calls for PBM reform legislation focus on transparency and reducing taxpayer burden, with potential savings of $5 billion. The Federal Trade Commission's findings underscore the urgency for ...

An FTC official told reporters the $7.3 billion figure could be an underestimation. PBM-affiliated pharmacy dispensing revenue increased at an annual growth rate of 42% from 2017 to 2021 ...

“The FTC staff’s second interim report finds that ... CEO of 46booklyn — said he’s glad not to be the only one working to expose PBM practices. He said he launched 46brooklyn in 2018 ...

The FTC’s investigation into PBM practices began in 2022. Last summer, the agency released a scathing interim report on the industry. It detailed how increasing concentration enabled the three ...

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs.